The new lab-on-a-chip’s key innovation is a 3D nanoengineering method that...
The new lab-on-a-chip’s key innovation is a 3D nanoengineering method that mixes and senses biological elements based on a herringbone pattern commonly found in nature, pushing exosomes into contact with the chip’s sensing surface much more efficiently in a process called “mass transfer.”
Source: Yong Zeng

Lab-on-a-chip detects cancer less invasively

A new ultrasensitive diagnostic device invented by researchers at the University of Kansas, The University of Kansas Cancer Center and KU Medical Center could allow doctors to detect cancer quickly from a droplet of blood or plasma, leading to timelier interventions and better outcomes for patients.

The “lab-on-a-chip” for “liquid biopsy” analysis detects exosomes — tiny parcels of biological information produced by tumor cells to stimulate tumor growth or metastasize. “Historically, people thought exosomes were like ‘trash bags’ that cells could use to dump unwanted cellular contents,” said lead author Yong Zeng, Docking Family Scholar and associate professor of chemistry at KU. “But in the past decade, scientists realized they were quite useful for sending messages to recipient cells and communicating molecular information important in many biological functions. Basically, tumors send out exosomes packaging active molecules that mirror the biological features of the parental cells. While all cells produce exosomes, tumor cells are really active compared to normal cells.”

The new lab-on-a-chip’s key innovation is a 3D nanoengineering method that mixes and senses biological elements based on a herringbone pattern commonly found in nature, pushing exosomes into contact with the chip’s sensing surface much more efficiently in a process called “mass transfer.” “People have developed smart ideas to improve mass transfer in microscale channels, but when particles are moving closer to the sensor surface, they’re separated by a small gap of liquid that creates increasing hydrodynamic resistance,” Zeng said. “Here, we developed a 3D nanoporous herringbone structure that can drain the liquid in that gap to bring the particles in hard contact with the surface where probes can recognize and capture them.”

Zeng compared the chip’s nanopores to a million little kitchen sinks: “If you have a sink filled with water and many balls floating on the surface, how do you get all the balls in contact with the bottom of the sink where sensors could analyze them? The easiest way is to drain the water.”

To develop and test the pioneering microfluidic device, Zeng teamed with a tumor-biomarker expert and KU Cancer Center Deputy Director Andrew Godwin at the KU Medical Center’s Department of Pathology & Laboratory Medicine, as well as graduate student Ashley Tetlow in Godwin’s Biomarker Discovery Lab. The collaborators tested the chip’s design using clinical samples from ovarian cancer patients, finding the chip could detect the presence of cancer in a minuscule amount of plasma. “Our collaborative studies continue to bear fruit and advance an area crucial in cancer research and patient care — namely, innovative tools for early detection,” said Godwin, professor and director of molecular oncology, pathology and laboratory medicine at KU Medical Center. “This area of study is especially important for cancers such as ovarian, given the vast majority of women are diagnosed at an advanced stage when, sadly, the disease is for the most part incurable.”

What’s more, the new microfluidic chips developed at KU would be cheaper and easier to make than comparable designs, allowing for wider and less-costly testing for patients. “What we created here is a 3D nanopatterning method without the need for any fancy nanofabrication equipment — an undergraduate or even a high school student can do it in my lab,” Zeng said. “This is so simple and low-cost it has great potential to translate into clinical settings. We’ve been collaborating with Dr. Godwin and other research labs at The KU Cancer Center and the molecular biosciences department to further explore the translational applications of the technology.”

According to Zeng, with the microfluidic chip’s design now proven using ovarian cancer as a model, the chip could be useful in detecting a host of other diseases. “Now, we’re looking at cell-culture models, animal models, and also clinical patient samples, so we are truly doing some translational research to move the device from the lab setting to more clinical applications,” he said. “Almost all mammalian cells release exosomes, so the application is not just limited to ovarian cancer or any one type of cancer. We’re working with people to look at neurodegenerative diseases, breast and colorectal cancers, for example.”

Subscribe to our newsletter

Related articles

Medical needles for high-tech cancer diagnostics

Medical needles for high-tech cancer diagnostics

Modern medicine needs better quality samples than traditional biopsy needles can provide, ultrasonically oscillating needles can improve treatment and reduce discomfort.

AI method can detect precursors to cervical cancer

AI method can detect precursors to cervical cancer

Using AI and mobile digital microscopy, researchers hope to create screening tools that can detect precursors to cervical cancer in women in resource-limited settings.

A pen to pin down the fringes of cancer

A pen to pin down the fringes of cancer

The MasSpec Pen has shown to accurately differentiate healthy and cancerous tissue from banked pancreas samples during surgery.

Pancreatic organoids on a chip platform

Pancreatic organoids on a chip platform

An organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer.

AI finds patterns of mutations in tumour images

AI finds patterns of mutations in tumour images

Researchers have developed an AI algorithm that uses computer vision to analyze tissue samples from cancer patients.

Sensor chip detects cancer biomarker in urine

Sensor chip detects cancer biomarker in urine

Researchers have used a chip-based sensor with an integrated laser to detect very low levels of a cancer protein biomarker in a urine sample.

3D-printed device exposes cancer cells

3D-printed device exposes cancer cells

A 3D-printed cell trap developed in the laboratory at Georgia Tech captures blood cells to isolate tumor cells from a blood sample.

Machine learning helps diagnose leukemia

Machine learning helps diagnose leukemia

Researchers at the University of Bonn show how artificial intelligence improves the evaluation of blood analysis data.

Device diagnoses Covid-19 from saliva samples

Device diagnoses Covid-19 from saliva samples

Engineers have designed a device that can detect SARS-CoV-2 from a saliva sample in about an hour. They showed that the diagnostic is just as accurate as the PCR tests now used.

Popular articles

Subscribe to Newsletter